Member Info for PL75

As a fellow OG dewamper I’m also expecting nothing to turn up next week.

I think it’s official, we’re on here every day just waiting for Sir Al to throw us a bone but all he does is tease us, whether we like it or not we’ve all fallen desperately in love with him. Stockholm Syndrome at it’s worst.

I thought my response deserved more credit. Anyway, hard to tell if you’ve had an episode in the space of this thread, pleased you’re back on the up

I’ll get you a nappy.

(I apologise in advance if you’ve got incontinence problems)

DOH85, much as I like you there is a line and belittling someone's geeky nature crosses over it as far as I'm concerned. To joke about someone who is a nerd is especially tasteless. They didn't choose to be that way. I''ll leave it at that

I don’t know whether to laugh or cry

We’re battle hardy, we’ve heard ‘very soon’ before... hope it all goes well for both companies though, it’s a great idea and innovation

No thanks, he’s bipolar, a bit too erratic for me, one day lamenting the end of the world, the next chasing fluffy rainbows

Sounds great, as long as there are facilities for his lordship’s donkey. Oh, and I’ll only attend if RK isn’t giving a speech, I’m not sure we’d find the time. So, anyone know of a venue large enough for the whole gang, otherwise everything they say won’t get 20 recs?

I asked the CEO, it’s a no go, he sees it as funding for ideas, they had the idea years ago and with Awacta are ready for implementation

Yeah, he’s a bit of a d.ck when you think about it... :o)

Just tell us Sir Al...

Wonder what phase we’re at?

RADx Tech aims to identify, accelerate development, scale up and deploy innovative point-of-care technologies throughout the fall of 2020. The program uses an “innovation funnel” design where applications quickly move through multiple stages of review with increasing scrutiny. This has been compared to a “shark tank” model. About 15-20% of RADx Tech applications will qualify for additional consideration and review. Of those applications, less than one-third will move to rigorous Phase 1 testing and validation through NIH’s Point-of-care Technology Research Network (POCTRN). If a project is judged successful at that point, rapid scale up and clinical testing gets underway, with substantial financial assistance provided. As of July 13, over 600 applications had been submitted, with 27 projects advancing to Phase 1 and one project advancing to Phase 2.

That’s the plan RD, it won’t be long before they’re disposable. If I fancy a new colour on the wall I’ll just get a new house...

£100/share excluding China

Cursed

How many do they need? :o)

Saint? I like it.

Sir Al, Patron Saint of Dribble

Triple whammy

But if you doubled it, you’d get £100 per share and that’s ridiculous compared with the perfectly sensible £50

Just copy and paste one of his old ones

Their potential market is smaller than ours, get very carried away